It is estimated that the Biodefense Market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in 2023. This market is projected to expand at a CAGR of 7.3% during the analysis period. The growing demand for vaccines, drugs, and medical devices provides companies with opportunit.
In recent years, the biodefense market has experienced significant growth due to increased government funding for biodefense programs and growing public.
/PRNewswire/ The biodefense market value is projected to reach USD 27.6 billion by 2028, according to a new research report by Global Market Insights Inc..